Latest filing published 04 Mar 2026 for Elevance Health, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +50.4%Entry US$39.75 · Close at T+365 US$59.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Felicia F. Norwood: trading record in brief
Felicia F. Norwood, EVP & President, GBD at Elevance Health, Inc. (39 filings) and a Director at Wells Fargo & Company/mn (8), has 47 filings published from July 5, 2018 to March 4, 2026. The record sets two scales side by side: 4 sales worth EUR 10.1 million, with a median of EUR 1,542,349, and 5 purchases of trivial size, EUR 2,982 in total, or 56% of market trades.
The sales are all at Elevance Health, Inc. in April 2024: EUR 6,986,033 on April 23, EUR 1,709,574 and EUR 1,375,125 on April 24. The purchases are at Wells Fargo & Company/mn: EUR 1,371 on March 16, 2023, EUR 1,244 and EUR 166 on August 1, 2022. The rest is 34 grants, 2 option exercises and 2 other filings.
Activity peaks in 2023 with 11 filings, ahead of 2024 (10); 2018 has only one. Four filings fall in the last twelve months, with no purchase and no sale.
At Wells Fargo, 4 of Norwood's trades fall within 30 days of a trade by Ellen R. Patterson, in the same direction. The publication delay is 2 days at the median.
Companies and markets linked to Felicia F. Norwood
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,951 shares0Common StockSEC:0001743548-26-000002:1
- 2,865 shares0Common StockSEC:0001743548-26-000002:2
- 496 shares@ US$284.030.5% of flowCommon StockSEC:0001743548-26-000002:3
- 1,421 shares@ US$294.076.0% of flowCommon StockSEC:0001743548-26-000002:0
- 3,035 shares0Common StockSEC:0001156039-25-000028:1
- 4,213 shares0Common StockSEC:0001156039-25-000028:2
- 2,613 shares@ US$395.5016.8% of flowCommon StockSEC:0001156039-25-000028:0
- 3,434 shares@ US$532.687.3% of flowCommon StockSEC:0001415889-24-011527:5
- 14,011 shares@ US$533.7329.6% of flowCommon StockSEC:0001415889-24-011527:1
- 100 shares@ US$534.740.2% of flowCommon StockSEC:0001415889-24-011527:2
- 2,043 shares@ US$238.271.9% of flowCommon StockSEC:0001415889-24-011527:3
- 2,765 shares@ US$532.145.8% of flowCommon StockSEC:0001415889-24-011527:4
- 5,473 shares@ US$238.2720.7% of flowCommon StockSEC:0001415889-24-011527:0
- 118 shares@ US$25.0018.6% of flowPreferred Shares, Series RSEC:0001415889-24-008571:0
- 2,405 shares0Common StockSEC:0001156039-24-000030:1
- 9,152 shares0Common StockSEC:0001156039-24-000030:2
- 4,902 shares@ US$499.1138.4% of flowCommon StockSEC:0001156039-24-000030:0
- 498 shares@ US$25.0080.3% of flowPreferred Shares, Series QSEC:0001127602-23-024442:0
- 1 shares@ US$1,276.637.2% of flowPreferred Shares, Series LSEC:0001127602-23-013693:1Canonical exit: 30 Oct 2022 (T+90)
- 5 shares@ US$17.840.5% of flowPreferred Shares, Series AASEC:0001127602-23-013693:2Canonical exit: 16 Jan 2023 (T+90)
- 6 shares@ US$18.000.6% of flowPreferred Shares, Series ZSEC:0001127602-23-013693:3Canonical exit: 16 Jan 2023 (T+90)
- 77 shares@ US$18.857.9% of flowPreferred Shares, Series ZSEC:0001127602-23-013693:4Canonical exit: 14 Jun 2023 (T+90)
- 9 shares@ US$18.9291.1% of flowPreferred Shares, Series DDSEC:0001127602-23-013693:0Canonical exit: 30 Oct 2022 (T+90)
- 4,754 shares@ US$468.788.9% of flowCommon StockSEC:0001156039-23-000029:3
- 2,292 shares0Common StockSEC:0001156039-23-000029:1
25 of 47 declarations
